Finance

Lists
002873:SHE
Guiyang Xintian Pharmaceutical Co Ltd
CNÂ¥8.38
-1.64%
(-0.14) 1D
Sep 10, 3:04:12 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002873...
Open
CNÂ¥8.52
High
CNÂ¥8.56
Low
CNÂ¥8.32
Mkt. cap
2.08B
Avg. vol.
7.15M
Volume
3.82M
Dividend
0.36%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
May 27, 2026
P/E ratio
286.10
52-wk high
CNÂ¥13.09
52-wk low
CNÂ¥7.04
EPS
CNÂ¥0.03
Shares outstanding
244.10M
No. of employees
1K
Open
CNÂ¥8.52
High
CNÂ¥8.56
Low
CNÂ¥8.32
Mkt. cap
2.08B
Avg. vol.
7.15M
Volume
3.82M
Dividend
0.36%
Quarterly dividend
CNÂ¥0.01
Ex-dividend date
May 27, 2026
P/E ratio
286.10
52-wk high
CNÂ¥13.09
52-wk low
CNÂ¥7.04
EPS
CNÂ¥0.03
Shares outstanding
244.10M
No. of employees
1K
About Guiyang Xintian Pharmaceutical Co Ltd
CEO-
Employees1.39K
FoundedAug 11, 1995
Headquarters-
SectorPharmaceutical industry
Websitegyxtyy.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
200.35M
191.09M
178.61M
153.22M
Cost of goods sold
54.09M
59.09M
49.13M
40.39M
Cost of revenue
54.09M
59.09M
49.13M
40.39M
Research and development expenses
12.03M
10.41M
9.30M
11.42M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
114.04M
125.40M
106.18M
92.88M
Operating expense
130.34M
137.34M
118.71M
106.25M
Total operating expenses
184.43M
196.43M
167.84M
146.64M
Operating income
15.92M
-5.35M
10.77M
6.57M
Other non operating income
-215.68K
505.88K
-40.98K
-7.13M
EBT including unusual items
10.40M
-6.90M
5.25M
2.96M
EBT excluding unusual items
11.83M
-9.94M
6.33M
3.96M
Income tax expense
-13.00K
167.36K
1.75M
1.60M
Effective tax rate
-0.12%
-2.42%
33.37%
53.89%
Other operating expenses
5.16M
1.56M
3.83M
1.35M
Net income
10.41M
-7.07M
3.50M
1.37M
Net profit margin
5.20%
-3.70%
1.96%
0.89%
Earnings per share
-
-
-
-
Interest and investment income
84.26K
124.27K
95.66K
4.52M
Interest expense
-3.96M
-5.23M
-4.50M
-
Net interest expenses
-3.88M
-5.10M
-4.40M
4.52M
Depreciation and amortization charges
-
-
-
-
EBITDA
23.68M
2.87M
18.99M
15.55M
Gain or loss from assets sale
-845.41K
781.86K
-
-
AI content may include mistakes. Learn more
Google apps